Cannabis Bioscience International Holdings, Inc. (CBIH)

OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
Jul 27, 2026, 1:03 PM EST
Market Cap2.41M -46.5%
Revenue (ttm)123.63K -64.1%
Net Income-515.29K
EPS-0.00
Shares Out 12.06B
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume100,150
Open0.0002
Previous Close0.0002
Day's Range0.0002 - 0.0002
52-Week Range0.0001 - 0.0008
Beta1.41
Analystsn/a
Price Targetn/a
Earnings DateSep 22, 2026

About CBIH

Cannabis Bioscience International Holdings, Inc. engages in the provision of educational systems that focuses on medical cannabis in the United States and Latin America, and internationally. The company offers educational services, such as continuing medical education courses for physicians; continuing legal education courses for attorneys; certification courses for physicians; certification for industry workers; general education seminars; and on-site training, as well as consulting, digital publishing, marketing, and franchising related to me... [Read more]

Sector Healthcare
Founded 2003
Employees 2
Stock Exchange OTCMKTS
Ticker Symbol CBIH
Full Company Profile

Financial Performance

In fiscal year 2025, CBIH's revenue was $303,022, an increase of 21.77% compared to the previous year's $248,841. Losses were -$548,820, -15.74% less than in 2024.

Financial Statements

News

CBIH Unveils Cannabinoid-Based Intranasal Platform for Alzheimer's Research

Houston, Texas--(Newsfile Corp. - July 20, 2026) - Alzheimer's disease is not only a scientific challenge; it is a human crisis affecting millions of patients, families, caregivers, and healthcare sys...

7 days ago - Newsfile Corp

Years of Preparation. One Regulatory Approval.

Houston, Texas--(Newsfile Corp. - July 15, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading on the OTC Markets under the ticker symbol CBIH, today annou...

12 days ago - Newsfile Corp

CBIH Announces Recognition Initiative Funded Through CEO's Personal Share Holdings

Houston, Texas--(Newsfile Corp. - July 6, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading on the OTC Markets under the ticker symbol CBIH, announces th...

21 days ago - Newsfile Corp

Cannabis Bioscience International Holdings Opens New Revenue Pathway with First VitaCookies Licensing Agreement

Houston, Texas--(Newsfile Corp. - June 22, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading on the OTC Markets under the ticker symbol CBIH, today annou...

5 weeks ago - Newsfile Corp

CBIH Announces Patent-Related Scientific Framework for PTSD-Focused Cannabinoid and Psilocybin Research

Houston, Texas--(Newsfile Corp. - June 15, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading under the ticker symbol CBIH, today announced a new chapter ...

6 weeks ago - Newsfile Corp

CBIH Advances Strategic Pathway to Bring VitaCookies' Science-Driven Functional Wellness Platform to Texas Consumers

Houston, Texas--(Newsfile Corp. - June 8, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public biotechnology company trading under the ticker symbol CBIH, today announced t...

7 weeks ago - Newsfile Corp

CBIH Puts CMS at the Center of the Board: Formal Coordination with Dr. Mehmet Oz's Team and an "Evidence Sprint 2026" Focused on Grants, Research and Clinical Evidence

Houston, Texas--(Newsfile Corp. - January 12, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading on the OTC Markets under the ticker symbol CBIH, announce...

7 months ago - Newsfile Corp

CBIH Launches Federal and Pharmaceutical Outreach Initiative to Accelerate Medical Cannabis Research in the Schedule III Transition

Houston, Texas--(Newsfile Corp. - January 5, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading on the OTC Markets under the ticker symbol CBIH, today ann...

7 months ago - Newsfile Corp

CBIH Announces New Patent Initiative Targeting Opioid Addiction Through Endocannabinoid Pathways

Houston, Texas--(Newsfile Corp. - December 29, 2025) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading on the OTC Markets under the ticker symbol CBIH, today a...

7 months ago - Newsfile Corp

CBIH Welcomes Federal Momentum Toward Cannabis Rescheduling as 2026 Opens a New Window to Accelerate Medical Innovation and Growth, with CBIH Positioned to Capitalize on Emerging Opportunities

Houston, Texas--(Newsfile Corp. - December 22, 2025) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH) (CBIH) announces a landmark corporate and industry moment following recent indicat...

7 months ago - Newsfile Corp

CBIH Announces Women-First Fertility Innovation Built on Nanoemulsion Delivery

Houston, Texas--(Newsfile Corp. - October 13, 2025) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH) today announced the addition of a patent-pending nanoemulsion formulation to its gr...

10 months ago - Newsfile Corp

CBIH Ignites Texas: Statewide TCUP Seminar Marks a New Era for Medical Cannabis-With Evidence, Safety, and Patient Dignity at the Center

Houston, Texas--(Newsfile Corp. - September 29, 2025) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH) announces a Statewide Educational Seminar Series on the TCUP Expansion, as Texas ...

10 months ago - Newsfile Corp

CBIH Welcomes Charles Tamburello to Its Board, Strengthening M&A Strategy

Houston, Texas--(Newsfile Corp. - November 4, 2024) - Cannabis Bioscience International Holdings (OTC Pink: CBIH) is thrilled to announce the appointment of Mr. Charles Tamburello as a new member of t...

1 year ago - Newsfile Corp

CBIH Strengthens Competitive Advantage with Rapid Expansion of Patent Filings

Houston, Texas--(Newsfile Corp. - October 28, 2024) - Cannabis Bioscience International Holdings (OTC Pink: CBIH) trading on the OTC Markets under the ticker symbol CBIH has reached a major milestone ...

1 year ago - Newsfile Corp

CBIH Pursues Regulatory Compliance and Market Growth with Essential Licensing Applications

Cannabis Bioscience International Holdings (OTCMKTS:CBIH) has initiated a strategic move to expand its presence in the cannabis market by filing applicati

2 years ago - GlobeNewsWire

CBIH Charts Path to Future Leadership in Cannabis Medicine

A letter from our desk HOUSTON, July 08, 2024 (GLOBE NEWSWIRE) -- Since the start of the year, Cannabis Bioscience International Holdings (OTCMKTS: CBIH) has embarked on a transformative journey invol...

2 years ago - GlobeNewsWire

CBIH: Unleashing the Potential of Cannabis for Tomorrow's Medicine

A letter from our desk Houston, Texas--(Newsfile Corp. - July 8, 2024) - Since the start of the year, Cannabis Bioscience International Holdings (OTC Pink: CBIH) has embarked on a transformative journ...

2 years ago - Newsfile Corp

CBIH Submits Groundbreaking Cannabis Patents for Breast and Pancreatic Cancer Treatments

Houston, Texas--(Newsfile Corp. - July 1, 2024) - Cannabis Bioscience International Holdings (OTC Pink: CBIH) is excited to announce the submission of our inaugural pair of patents, focusing on novel ...

2 years ago - Newsfile Corp

CBIH Announces Strategic Advancements Initiated by Recently Appointed Director, Setting a New Paradigm and Driving Visionary Change

As CBIH prepares for the manufacturing and distribution of its products, the potential collaboration might involve this entity acting as CBIH's distributor

2 years ago - GlobeNewsWire

CBIH's Recently Appointed Director Unveils Groundbreaking Product Strategies and Potential Partnership with Industry Leader

Houston, Texas--(Newsfile Corp. - June 24, 2024) - Cannabis Bioscience International Holdings (OTC Pink: CBIH) is thrilled to introduce the groundbreaking strategies formulated by its freshly appointe...

2 years ago - Newsfile Corp

Unleashing the Potential of Cannabis: Cannabis Bioscience International Holdings Reaches a Historic Valuation

HOUSTON, June 17, 2024 (GLOBE NEWSWIRE) -- Cannabis Bioscience International Holdings, Inc. (OTC Pink: CBIH), a company dedicated to medicinal cannabis research for over 15 years, has achieved a 2 bil...

2 years ago - GlobeNewsWire

CBIH Achieves $2 Billion Valuation Following StoneBridge Advisory Assessment

Houston, Texas--(Newsfile Corp. - June 17, 2024) - Cannabis Bioscience International Holdings (OTC PINK: CBIH) has been valued at $2 Billion following a rigorous evaluation by StoneBridge Advisory, a ...

2 years ago - Newsfile Corp

CBIH and Vita Biotech Forge Alliance to Propel Clinical Studies Forward

“Collaboration in clinical trials ensures data integrity and safety, advancing both organizations' missions and improving patient care,” says Dr. Jennifer

2 years ago - GlobeNewsWire

Vita Biotech Retains CBIH Services for Clinical Studies

Houston, Texas--(Newsfile Corp. - June 5, 2024) - Vita Biotech Research has entered into a significant partnership with Cannabis Bioscience International Holdings (OTC Pink: CBIH), to fund the clinica...

2 years ago - Newsfile Corp

Cannabis Bioscience International Holdings Engages StoneBridge Advisory for Comprehensive Company Valuation

Houston, Texas--(Newsfile Corp. - May 29, 2024) - Cannabis Bioscience International Holdings (OTC Pink: CBIH) announces the engagement of StoneBridge Advisory (stonebridgema.com) for CBIH's company va...

2 years ago - Newsfile Corp